NCT05426681View on ClinicalTrials.gov

Spinal Cord Injury Neuroprotection With Glyburide

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 7, 2022

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2028

Conditions
Acute Spinal Cord Injury
Interventions
DRUG

GlyBURIDE Oral Tablet

"Enrolled patients will receive 12 doses of Glyburide starting within 8 hours of spinal cord injury. The dosing regimen involves an initial dose of 1.25mg followed by 11 consecutive doses of 0.625 mg every 6 hours. The total daily dose of Glyburide on Day 1, Day 2, and Day 3 will be 3.125 mg, 2.5 mg, and 2.5 mg respectively.~Intervention: Drug: Glyburide"

Trial Locations (1)

40536

RECRUITING

University of Kentucky, Lexington

All Listed Sponsors
lead

University of Kentucky

OTHER